These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 22237239

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Acute inflammatory demyelinating polyneuropathy associated with pegylated interferon alpha 2a therapy for chronic hepatitis C virus infection.
    Khiani V, Kelly T, Shibli A, Jensen D, Mohanty SR.
    World J Gastroenterol; 2008 Jan 14; 14(2):318-21. PubMed ID: 18186575
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Vitiligo after combination therapy of pegylated interferon-α-2a, ribavirin and vitamin D in a patient with chronic hepatitis C.
    Oiso N, Sato M, Kawada A.
    J Dermatol; 2013 Sep 14; 40(9):772-3. PubMed ID: 23855823
    [No Abstract] [Full Text] [Related]

  • 25. Severe autoimmune hemolytic anemia in a patient with chronic hepatitis C during treatment with Peg interferon alfa-2a and ribavirin.
    Ennaifer R, Cheikh M, Romdhane H, Hefaiedh R, Ben Nejma H, Bel Hadj N.
    Tunis Med; 2014 Jan 14; 92(1):42-3. PubMed ID: 24879173
    [No Abstract] [Full Text] [Related]

  • 26. Interferon alfa, peginterferon alfa and retinopathy.
    Prescrire Int; 2006 Apr 14; 15(82):61-2. PubMed ID: 16607695
    [Abstract] [Full Text] [Related]

  • 27. Reversible decompensated liver disease as a possible complication of pegylated-interferon alfa 2b and ribavirin for recurrent hepatitis C.
    Mukherjee S.
    J Gastroenterol Hepatol; 2004 Jun 14; 19(6):723-4. PubMed ID: 15151639
    [No Abstract] [Full Text] [Related]

  • 28. [A case of chronic inflammatory demyelinating polyradiculoneuropathy after treatment with pegylated interferon α-2a in a patient with chronic hepatitis B virus infection].
    Naito H, Takeda I, Segawa A, Tsuge M, Maruyama H, Matsumoto M.
    Rinsho Shinkeigaku; 2016 Oct 28; 56(10):672-677. PubMed ID: 27680223
    [Abstract] [Full Text] [Related]

  • 29. Penile paraffinoma developing during treatment with pegylated interferon alfa-2a for chronic hepatitis C virus infection.
    Bachmeyer C, Moguelet P, Gombeaud T, Sbidian E, Aractingi S.
    Arch Dermatol; 2011 Oct 28; 147(10):1232-3. PubMed ID: 22006152
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Peginterferon alfa-2a (40KD): a potent long-acting form of interferon alfa-2a for the treatment of hepatitis C.
    Modi MW, Lamb MW, Shiomi M.
    Adv Exp Med Biol; 2003 Oct 28; 519():59-67. PubMed ID: 12675208
    [No Abstract] [Full Text] [Related]

  • 33. Simultaneous occurrence of pleural effusion and interstitial pneumonitis after treatment with pegylated interferon for hepatitis C virus infection.
    Ji F, Li Z, Xue H, Liu L, Deng H.
    South Med J; 2011 Feb 28; 104(2):140-2. PubMed ID: 21206334
    [Abstract] [Full Text] [Related]

  • 34. [Sarcoidosis associated with the treatment of hepatitis C: case report and Spanish literature review].
    Trullàs JC, Hernández-Marcet P, Bisbe J.
    Med Clin (Barc); 2011 May 21; 136(14):649-50. PubMed ID: 21051060
    [No Abstract] [Full Text] [Related]

  • 35. Adverse response to pegylated interferon therapy in two patients with chronic hepatitis C.
    Thomas WL, Ramos F, Hospenthal DR.
    Hawaii Med J; 2003 Aug 21; 62(8):163-4. PubMed ID: 14533347
    [Abstract] [Full Text] [Related]

  • 36. [Thyroid dysfunction in patients with chronic hepatitis C treated with pegylated interferon alpha].
    Montero-Tinnirello J, de la Fuente-Aguado J, Rodríguez-Pecci MS, Fernández-Fernández FJ.
    Rev Clin Esp; 2011 Sep 21; 211(8):436-8. PubMed ID: 21546017
    [No Abstract] [Full Text] [Related]

  • 37. Cutaneous sarcoidosis associated with pegylated interferon alfa and ribavirin therapy in a patient with chronic hepatitis C.
    Rogers CJ, Romagosa R, Vincek V.
    J Am Acad Dermatol; 2004 Apr 21; 50(4):649-50. PubMed ID: 15034524
    [No Abstract] [Full Text] [Related]

  • 38. Pegylated interferon associated lichen planus at the injection site.
    Ergül B, Koçak E, Akbal E, Köklü S, Astarci HM.
    Acta Gastroenterol Belg; 2011 Dec 21; 74(4):591-2. PubMed ID: 22319976
    [No Abstract] [Full Text] [Related]

  • 39. Cotton-wool spots and retinal hemorrhages. Interferon-associated retinopathy.
    Andreoli MT, Lim JI.
    JAMA Ophthalmol; 2014 Apr 01; 132(4):503-4. PubMed ID: 24723156
    [No Abstract] [Full Text] [Related]

  • 40. [Pegylated interferon alfa-2a. Improved prognosis in hepatitis C].
    MMW Fortschr Med; 2002 Sep 19; 144(38):59. PubMed ID: 12395712
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.